Learn More
CERILLIANT™ (+/-)-threo-Ritalinic acid-D10 Hydrochloride Solution, 1.0 mg/mL in Methanol, Sold by MilliporeSigma™ Supelco™
Certified reference material
Supplier: MilliporeSigma Supelco R0271ML
Description
Ritalinic acid is the major urinary metabolite of methylphenidate, which is approved for treatment of ADHD (Attention-Deficit Hyperactivity Disorder) and narcolepsy. This new stable-labeled internal standard is suitable for a wide variety of GC/MS and LC/MS applications from clinical toxicology and urine drug testing to forensic analysis and isotope dilution methods.
Specifications
| 67-56-1 | |
| UN 1230 - class 3 - PG 2 - Methanol, solution | |
| 265.80 | |
| 1 mL |
| C13H7D10NO2 · HCl | |
| 1.0 mg/mL in methanol (as free base) | |
| Ampule | |
| 9.7°C (49.5°F) - closed cup |
Safety and Handling
H331-H370
H311
Recommended Storage : -20°C
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
CERILLIANT is a registered trademark of Cerilliant Corporation